IKS Health Q2 FY26 results: Revenue up 21.5%, PAT up 60% YoY

Revenue growth above 20%Profit growth above 25%Results View source PDF Explain this filing

IKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹1597.00

prior close

₹1579.30

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%-1.8% vs market

IT Enabled Services peers, median of 70sector+0.3%-1.1% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Smallcap 250 and 1.1 pts less than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

-0.1

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+1.0-1.8+0.3-1.1

Next day

-1.9+0.3-2.2+0.4-2.3

-2.2+0.9-3.1+0.4-2.6

+3.1+1.7+1.4+1.2+1.9

+4.3+2.1+2.2+1.1+3.2

+5.5+1.3+4.2+0.9+4.6

+3.5+0.4+3.0-0.3+3.8

15d

+4.0+3.5+0.5+0.6+3.4

+3.8+0.6+3.2-3.9+7.7

+5.5+0.9+4.6-4.7+10.3

-17.9-6.6-11.4-18.9+0.9

UpDownMarket · Nifty Smallcap 250Sector · IT Enabled Services peers, median of 70Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Inventurus Knowledge Solutions (IKS Health) reported consolidated Q2 FY26 revenue of Rs 7,810.91 mn, up 21.5% YoY from Rs 6,427.84 mn. Consolidated PAT jumped 60% YoY to Rs 1,807.19 mn. H1 FY26 revenue grew 18.6% to Rs 15,211.86 mn with PAT up 59% at Rs 3,322.58 mn. Standalone Q2 revenue rose 48% to Rs 3,556.91 mn; PAT up 50% to Rs 1,383.99 mn. Consolidated EPS stood at Rs 10.81. Auditor Price Waterhouse issued an unmodified review report. The company also invested about $17 mn in IKS WWMG MSO LLC, now a 48% associate.

Likely market impact

Strong quarter with 21% revenue and 60% profit growth. Positive earnings momentum likely to support stock sentiment and investor confidence.